A randomized controlled study comparing community based with health facility based direct observation of treatment models on patients' satisfaction and TB treatment outcome in Nigeria

Trans R Soc Trop Med Hyg. 2015 Dec;109(12):783-92. doi: 10.1093/trstmh/trv091.


Background: Directly observed treatment short-course (DOTS) strategy is an effective mode of treating TB. We aimed to study the cost effectiveness and patients' satisfaction with home based direct observation of treatment (DOT), an innovative approach to community-based DOT (CBDOT) and hospital based DOT (HBDOT).

Methods: A randomized controlled trial involving 150 newly diagnosed pulmonary TB patients in four TB clinics in Ile Ife , Nigeria, was done. They were randomly assigned to receive treatment with anti TB drugs for the intensive phase administered at home by a TB worker (CBDOT) or at the hospital (HBDOT). Outcome measures were treatment completion/default rates, cost effectiveness and patients' satisfaction with care using a 13 item patients satisfaction questionnaire (PS-13) at 2 months. This trial was registered with pactr.org: number PACTR 201503001058381.

Results: At the end of intensive phase, 15/75 (20%) and 2/75 (3%) of patients in the HBDOT and CBDOT, respectively had defaulted from treatment, p= 0.01. Of those with pretreatment positive sputum smear, 97% (68/70) on CBDOT and 54/67 (81%) on HBDOT were sputum negative for AFB at the end of 2 months of treatment, p=0.01. The CBDOT method was associated with a higher patient satisfaction score compared with HBDOT (OR 3.1; 95% CI 1.25-7.70), p=0.001.The total cost for patients was higher in HBDOT (US$159.38) compared with the CBDOT (US$89.52). The incremental cost effectiveness ratio was US$410 per patient who completed the intensive phase treatment with CBDOT.

Conclusions: CBDOT is a cost effective approach associated with better compliance to treatment and better patient satisfaction compared to HBDOT.

Keywords: Cost effectiveness; Direct observation of treatment; Nigeria; Patient satisfaction; Tuberculosis.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Community Health Services / methods
  • Cost-Benefit Analysis
  • Directly Observed Therapy / economics
  • Directly Observed Therapy / methods*
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Medication Adherence / statistics & numerical data
  • Middle Aged
  • Nigeria
  • Patient Satisfaction*
  • Regression Analysis
  • Tuberculosis, Pulmonary / drug therapy*
  • Young Adult


  • Antitubercular Agents